| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -41.21M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ORKA returned +599.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +256.2% |
| 1 year | +599.2% |
| 5 years | +441.4% |
| 10 years | -67.3% |
| All-time high | $55,112,400.00 (Feb 2000) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ORKA would be worth today ›No. Oruka Therapeutics, Inc. has not paid a dividend in the past 12 months.
Oruka Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol ORKA.
Oruka Therapeutics, Inc. is part of the Healthcare sector.
Oruka Therapeutics, Inc. has a market cap of 7.15B USD, based on the latest quote.
Oruka Therapeutics, Inc. is expected to report earnings around Nov 11, 2026. That date is an estimate and has not been confirmed by the company.
